SERA · XBRL financial data

Sera Prognostics financial statements, every fiscal year

The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (SERA's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	—	—	306	77	81
Revenue from contracts with customers	82	268	306	77	81
Cost of revenue	—	—	210	82	164
Research and development	11,019	14,244	15,225	14,730	13,171
General and administrative	14,093	16,784	16,343	16,129	16,702
Total operating expenses	35,477	45,920	40,127	36,712	36,585
Operating income (loss)	(35,395)	(45,652)	(39,821)	(36,635)	(36,504)
Interest expense	—	—	55	28	9
Income tax expense (benefit)	0	0	0	0	0
Net income (loss)	(35,009)	(44,186)	(36,242)	(32,898)	(31,928)
Earnings per share, basic USD per share	(2.33)	(1.43)	(1.16)	(0.99)	(0.67)
Earnings per share, diluted USD per share	(2.33)	(1.43)	(1.16)	(0.99)	(0.67)
Weighted average shares, basic thousands of shares	15,003	30,943	31,201	33,157	47,662
Weighted average shares, diluted thousands of shares	15,003	30,943	31,201	33,157	47,662

Fiscal years (SERA's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	58,932	29,878	3,880	4,043	3,944
Marketable securities	46,183	52,826	45,199	42,193	35,257
Marketable securities, non-current	34,848	21,329	30,841	21,973	56,579
Accounts receivable	27	113	160	34	12
Prepaid and other current assets	1,993	1,308	795	1,311	1,557
Total current assets	110,251	90,125	61,344	47,600	40,770
Property and equipment, net	1,773	—	—	—	—
Right-of-use asset	—	1,707	1,180	613	2,402
Total assets	147,029	116,329	95,441	72,575	101,933
Accounts payable	1,197	1,548	1,046	1,969	862
Total current liabilities	8,411	15,538	24,443	24,770	24,188
Lease liability, non-current	0	1,222	644	0	2,337
Total liabilities	8,465	17,386	25,283	24,772	26,525
Accumulated deficit	(166,468)	(210,654)	(246,896)	(279,794)	(311,722)
Total stockholders' equity	138,564	98,943	70,158	47,803	75,408
Total liabilities and equity	147,029	116,329	95,441	72,575	101,933

Fiscal years (SERA's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(35,009)	(44,186)	(36,242)	(32,898)	(31,928)
Stock-based compensation	3,130	5,055	5,273	7,013	5,110
Depreciation and amortization	659	756	900	833	940
Net cash from operating activities	(31,636)	(34,610)	(27,188)	(14,189)	(25,623)
Purchases of property and equipment	1,304	791	128	56	726
Net cash from investing activities	(82,559)	5,551	438	11,743	(28,502)
Proceeds from issuing common stock	—	—	—	—	53,610
Net cash from financing activities	159,594	5	752	2,609	54,026

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Sera Prognostics	3,986	42	(7,298)*	not reported	5.9 quarters	Q3 FY26 10-QSep 30, 2026
Freenome	437	not reported	(130)*	not reported	3.4 quarters	Q2 FY26 10-QJun 30, 2026
Exagen	24,588	19,941	3,988*	24.2M	—	Q2 FY26 10-QJun 30, 2026
Fulgent Genetics	26,305	85,389	(23,758)*	27.5M	10.8 quarters	Q2 FY26 10-QJun 30, 2026
Biodesix	29,996	26,861	(1,562)*	10.6M	19.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.